A decision was taken to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate LP-001680 dated 02.05.2012 issued by GlaxoSmithKline Trading, Russia):
TROBALT (trade name of the medicinal product)
Retigabeen (international non-proprietary or chemical name of the medicinal product)
Tablets, film-coated,
50 mg, 100 mg, 200 mg, 300 mg, 400 mg (dosage form, dosage)
Glaxo Wellcome SA, Spain
Avda, de Extremadura 3, 09400 Aranda de Duero, Burgos, Spain (name and address of the manufacturer of the medicinal product)
on the basis of filing an application by an authorized legal entity of ZAO GlaxoSmithKline Trading to cancel the state registration of the medicinal product.